To validate the expression results comparing Probioglat with GA for key inflammation and MS-related genes, two chemokines (CXCL10, FDR p-value < 0.0006 with FC 1.46 and CCL5, FDR p-value < 0.02 with FC 1.09), two matrix metalloproteinases (MMP1, FDR p-value < 0.002 with FC 1.50 and MMP9, FDR p-value < 2.8e-6 with FC 1.29) and a non-secreted cell surface marker (CD9, FDR p-value < 0.002 with FC 1.15) that is a component of myelin and a marker of myelinogenic progenitor cells16 were tested independently by robust qRT-PCR analysis (see Methods). The gene discussed is CCL5; the disease is myeloid sarcoma.